Sign In | Join Free | My chinaqualitycrafts.com
China Hangzhou Aichek Medical Technology Co.,Ltd logo
Hangzhou Aichek Medical Technology Co.,Ltd
Hangzhou Aichek Medical Technology Co.,Ltd
Active Member

4 Years

Home > Infectious Disease Rapid Test Kits >

Swab 97.7% Influenza AB Test Infectious Disease Rapid Test Kits

Hangzhou Aichek Medical Technology Co.,Ltd
Contact Now

Swab 97.7% Influenza AB Test Infectious Disease Rapid Test Kits

Brand Name : Aichek

Model Number : FLU-A01

Certification : CE

Place of Origin : China

MOQ : 5000 Test

Price : negotiable

Payment Terms : T/T

Supply Ability : negotiable

Packaging Details : 40box/carton

Storage : 2℃-30℃

Sample Type : Swab

User : Professional

Accuracy : 99.6% (97.7%-99.9%)

Certificate : CE ISO 13485

OEM : OEM customized packing avaliable

Formats : 25T/box 1T/box

After-sales Service : Available

Key words : COVID-19 and Influenza A+B Antigen Rapid Test

For the crowd : Preliminary screening of infected people

Contact Now

Double check COVID-19 and Influenza A+B Antigen Rapid Test with CE

Product Name Double check COVID-19 and Influenza A+B Antigen Rapid Test with CE
Formats Strip(3mm)Device(4mm)
Place of Origen China
Specimen swab
Read Time 15 minutes
Shelf life 2 years
Package 25 device/box or 50 strip/Box
Storage 2℃-30℃


For professional in vitro diagnostic use only

【INTENDED USE】

The Influenza A+B Rapid Test Device is a rapid chromatographic immunoassay for the qualitative detection of influenza A and B antigens in nasal swab or throat swab or nasal aspirate specimens. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections.

The COVID-19 Antigen Rapid Test device is a lateral flow chromatographic immunoassay for the qualitative detection of the nucleocapsid(N) protein antigen from SARS-CoV-2 in nasopharyngeal swab, oropharyngeal swab. It provides an aid in the diagnosis of infection with 2019-nCOV.

Sensitivity, Specificity and Accuracy

The Influenza A+B Rapid Test Device (Swab/Nasal Aspirate) has been evaluated with specimens obtained from the patients. RT-PCR is used as the reference method for the Influenza A+B Rapid Test Device (Swab/Nasal Aspirate). Specimens were considered positive if RT-PCR indicated a positive result. Specimens were considered negative if RT-PCR indicated a negative result Nasal Swab Specimen.

Accuracy
A side-by-side comparison was conducted by the results of the test reagent and RT-PCR. 420 clinical swab specimens (including
Ct≤33 and Ct>33)were evaluated, 111 were positive and 309 were negative. Base on the results from the clinical studies, the
statistical analysis was made as follows:
Clinical sensitivity:98.10% (95% CI: 93.32%~99.48%)
Clinical specificity:99.68% (95% CI: 98.19%~99.94%)
Total Coincidence rate:99.28% (95% CI: 97.89%~99.75%).
Clinical sensitivity:97.30% (95% CI: 92.35%~99.08%)
Clinical specificity:99.68% (95% CI: 98.19%~99.94%)
Total Coincidence rate:99.05% (95% CI: 97.58%~99.63%).

Product Tags:

Swab 97.7% Influenza AB Test

      

97.7% Influenza AB Test

      

Swab influenza ab test kit

      
Quality Swab 97.7% Influenza AB Test Infectious Disease Rapid Test Kits for sale

Swab 97.7% Influenza AB Test Infectious Disease Rapid Test Kits Images

Inquiry Cart 0
Send your message to this supplier
 
*From:
*To: Hangzhou Aichek Medical Technology Co.,Ltd
*Subject:
*Message:
Characters Remaining: (0/3000)